MRI Effects of Pegvorhyaluronidase Alfa (PEGPH20) in Pancreatic Ductal Adenocarcinoma
Clinical trial NCT04134468 · WITHDRAWN
Trial details
- NCT number
- NCT04134468
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2021-02-11
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.